ISRCTN28863830已完成不适用
The effects of Immunoglobulin M (IgM) enriched immunoglobulin preparations in patients with severe sepsis
Istanbul University (Turkey)0 个研究点目标入组 39 人开始时间: 2002年4月29日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 39
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •Thirty-nine patients with severe sepsis, defined as:
- •1. Temperature of greater than 38°C or less than 36°C
- •2. Heart rate of greater than 90 beats/min
- •3. Respiratory rate greater than 20/min or arterial carbon dioxide pressure (PaCO2) less than 32 mmHg
- •4. White blood cell count greater than 12000/mm^3 or less than 4000/mm^3
- •5. Documented infection and dysfunction of an organ or hypotension
排除标准
- •Does not comply with above inclusion criteria
研究者
相似试验
已完成
不适用
IgM-enriched Immunoglobulin Attenuates Systemic Endotoxin Activity in Early Severe SepsisSepsisNCT02444871Goethe University30
进行中（未招募）
1 期
Clinical study evaluating the efficacy and safety of IgM-enriched immunoglobulin therapy with a personalized dose based on serum IgM-titers vs. IgM-enriched immunoglobulin standard dose in patients with septic shockSeptic shockMedDRA version: 23.1Level: LLTClassification code 10040580Term: Shock septicSystem Organ Class: 10021881 - Infections and infestationsMedDRA version: 23.1Level: PTClassification code 10040070Term: Septic shockSystem Organ Class: 10021881 - Infections and infestationsEUCTR2018-001613-33-ITAZIENDA OSPEDALIERO-UNIVERSITARIA DI MODENA356
尚未招募
不适用
Comparative study for human papilloma virus detection in oral and oropharyngeal carcinomasCTRI/2020/10/028543GMCH
已完成
4 期
Characterization of the immuno-modulatory effects of Tecfidera in multiple sclerosis patients: exploration of drug mechanism and methodological feasibility.Reduced lymphocyte count. Reduced white bloodcell count.10047954NL-OMON42490Centre for Human Drug Research16
尚未招募
2 期
Immuno -Modulatory Potential of AyurRaksha Kit and Its Preventive Impact on COVID 19 In Delhi PoliceCTRI/2021/08/035745Ministry of AYUSH